Fidelity Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30M | Buy |
546,100
+4,588
| +0.8% | +$252K | ﹤0.01% | 1564 |
|
2025
Q1 | $38.3M | Buy |
541,512
+303,355
| +127% | +$21.4M | ﹤0.01% | 1460 |
|
2024
Q4 | $15.7M | Buy |
238,157
+31,619
| +15% | +$2.08M | ﹤0.01% | 1800 |
|
2024
Q3 | $14.5M | Buy |
206,538
+36,877
| +22% | +$2.59M | ﹤0.01% | 1812 |
|
2024
Q2 | $14M | Sell |
169,661
-316,822
| -65% | -$26.1M | ﹤0.01% | 1772 |
|
2024
Q1 | $42.5M | Sell |
486,483
-583,498
| -55% | -$51M | ﹤0.01% | 1380 |
|
2023
Q4 | $103M | Buy |
1,069,981
+356,184
| +50% | +$34.3M | 0.01% | 995 |
|
2023
Q3 | $63.2M | Buy |
713,797
+166,219
| +30% | +$14.7M | 0.01% | 1167 |
|
2023
Q2 | $47.5M | Sell |
547,578
-4,071
| -0.7% | -$353K | ﹤0.01% | 1296 |
|
2023
Q1 | $53.6M | Buy |
551,649
+86,382
| +19% | +$8.4M | ﹤0.01% | 1239 |
|
2022
Q4 | $48.2M | Sell |
465,267
-218,745
| -32% | -$22.6M | ﹤0.01% | 1270 |
|
2022
Q3 | $58M | Buy |
684,012
+169,732
| +33% | +$14.4M | 0.01% | 1189 |
|
2022
Q2 | $42.6M | Buy |
514,280
+248,829
| +94% | +$20.6M | ﹤0.01% | 1339 |
|
2022
Q1 | $20.5M | Buy |
265,451
+84,230
| +46% | +$6.49M | ﹤0.01% | 1772 |
|
2021
Q4 | $16M | Buy |
181,221
+110,600
| +157% | +$9.77M | ﹤0.01% | 1923 |
|
2021
Q3 | $5.46M | Buy |
70,621
+3,643
| +5% | +$282K | ﹤0.01% | 2334 |
|
2021
Q2 | $5.59M | Sell |
66,978
-10,049
| -13% | -$838K | ﹤0.01% | 2297 |
|
2021
Q1 | $5.82M | Sell |
77,027
-2,559
| -3% | -$193K | ﹤0.01% | 2213 |
|
2020
Q4 | $6.98M | Sell |
79,586
-588,553
| -88% | -$51.6M | ﹤0.01% | 2087 |
|
2020
Q3 | $50.8M | Sell |
668,139
-1,315,019
| -66% | -$100M | 0.01% | 1183 |
|
2020
Q2 | $245M | Buy |
1,983,158
+246,834
| +14% | +$30.4M | 0.03% | 530 |
|
2020
Q1 | $147M | Buy |
1,736,324
+1,101,071
| +173% | +$93M | 0.02% | 612 |
|
2019
Q4 | $53.7M | Buy |
635,253
+42,371
| +7% | +$3.58M | 0.01% | 1179 |
|
2019
Q3 | $40M | Sell |
592,882
-223,054
| -27% | -$15M | ﹤0.01% | 1274 |
|
2019
Q2 | $69.9M | Sell |
815,936
-505,130
| -38% | -$43.3M | 0.01% | 1070 |
|
2019
Q1 | $117M | Buy |
1,321,066
+374,021
| +39% | +$33.2M | 0.01% | 841 |
|
2018
Q4 | $80.6M | Sell |
947,045
-353,443
| -27% | -$30.1M | 0.01% | 942 |
|
2018
Q3 | $126M | Sell |
1,300,488
-809,816
| -38% | -$78.5M | 0.01% | 856 |
|
2018
Q2 | $199M | Sell |
2,110,304
-2,035,754
| -49% | -$192M | 0.02% | 665 |
|
2018
Q1 | $336M | Sell |
4,146,058
-1,824,275
| -31% | -$148M | 0.04% | 474 |
|
2017
Q4 | $532M | Sell |
5,970,333
-2,049,058
| -26% | -$183M | 0.06% | 335 |
|
2017
Q3 | $746M | Sell |
8,019,391
-1,276,131
| -14% | -$119M | 0.09% | 232 |
|
2017
Q2 | $844M | Sell |
9,295,522
-407,488
| -4% | -$37M | 0.1% | 206 |
|
2017
Q1 | $852M | Buy |
9,703,010
+812,496
| +9% | +$71.3M | 0.11% | 197 |
|
2016
Q4 | $736M | Sell |
8,890,514
-1,189,027
| -12% | -$98.5M | 0.1% | 221 |
|
2016
Q3 | $933M | Sell |
10,079,541
-993,804
| -9% | -$91.9M | 0.12% | 172 |
|
2016
Q2 | $862M | Sell |
11,073,345
-2,386,118
| -18% | -$186M | 0.12% | 184 |
|
2016
Q1 | $1.11B | Sell |
13,459,463
-1,150,376
| -8% | -$94.9M | 0.15% | 138 |
|
2015
Q4 | $1.53B | Sell |
14,609,839
-1,979,702
| -12% | -$207M | 0.21% | 91 |
|
2015
Q3 | $1.75B | Buy |
16,589,541
+2,730,979
| +20% | +$288M | 0.25% | 76 |
|
2015
Q2 | $1.9B | Buy |
13,858,562
+1,975,747
| +17% | +$270M | 0.24% | 76 |
|
2015
Q1 | $1.48B | Sell |
11,882,815
-1,548,774
| -12% | -$193M | 0.19% | 122 |
|
2014
Q4 | $1.21B | Buy |
13,431,589
+850,778
| +7% | +$76.9M | 0.16% | 138 |
|
2014
Q3 | $908M | Buy |
12,580,811
+3,362,794
| +36% | +$243M | 0.12% | 181 |
|
2014
Q2 | $573M | Buy |
9,218,017
+1,919,366
| +26% | +$119M | 0.08% | 296 |
|
2014
Q1 | $498M | Sell |
7,298,651
-495,810
| -6% | -$33.8M | 0.07% | 310 |
|
2013
Q4 | $548M | Sell |
7,794,461
-3,895,285
| -33% | -$274M | 0.08% | 281 |
|
2013
Q3 | $844M | Sell |
11,689,746
-697,180
| -6% | -$50.4M | 0.13% | 174 |
|
2013
Q2 | $691M | Buy |
+12,386,926
| New | +$691M | 0.11% | 203 |
|